Industry News In Brief (October 17, 2016)
Charting the future of public relations
Holmes Report
News and insights from the global PR industry

Industry News In Brief (October 17, 2016)

A new PR Council chair; a new biotech PR specialist; a new brand for McBee; a new London office for Gould.

Holmes Report

NEW YORK — The PR Council has named Edelman COO Matt Harrington as chair. Joining Harrington as executive committee officers are Carrie Jones (JPA Health Communications) as secretary and Todd Hansen (O’Malley Hansen Communications) as treasurer. The PRC also announced the election of its new board directors: Gail Heimann (Weber Shandwick), Barri Rafferty (Ketchum), Dale Bornstein (MBooth), Jon Silvan (Global Strategy Group), Anne Green (Cooper Katz).

SEATTLE—Former Biotechnology Industry Organization vice president of communications Dan Eramian and former president of Georgia Bio Charles Craig have formed Opus Biotech Communications, with offices in Seattle and Atlanta. The firm will offer reputation management, public relations and investor relations services to early-stage companies and communication audits and programs for established companies.

WASHINGTON, DC—McBee Strategic Consulting, a government relations and strategic communications firm, has rebranded as Signal Group, which it says reflects the company's new mission “to shape the future for clients and our world through integrated services” backed by the deep regulatory and policy expertise of its parent Wiley Rein.

LONDON—Gould+Partners, which specializes in mergers and acquisitions in the Psector, has named Sally Tilleray senior advisor, London. Tilleray, who is non-executive chairman of Cognito and owner of Sally Tilleray Consulting, will be responsible for facilitating transactions among buyers and sellers of creative services firms throughout the UK market. Previously, she was group chief operating officer and finance director of Huntsworth and led European operations of Predictive Technology Group.

Article tags
View Style:

Load 3 More
comments powered by Disqus